A. Sugawara et al., Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes, HYPERTENS R, 24(3), 2001, pp. 229-233
Peroxisome proliferator-activated receptor (PPAR)-gamma ligands thiazolidin
ediones (TZDs) have recently been reported to be anti-hypertensive and anti
-atherosclerotic. We have previously shown that one of the TZDs troglitazon
e significantly suppressed the transcription of both thromboxane receptor (
TXR) and angiotensin II type 1 receptor(AT1R) genes in vascular smooth musc
le cells (VSMCs) by activating PPAR-gamma, In the present study, we compare
d the effects of troglitazone and other TZDs on the transcription of these
genes. TXR and AT1R mRNAs in rat VSMCs were determined by semi-quantitative
RT-PCR, Luciferase chimeric constructs containing either the 989-bp rat TX
R gene promoter or the 1,969-bp rat AT1R gene promoter were transiently tra
nsfected into VSMCs, The cells were incubated with troglitazone, RS-1455 Ia
derivative of troglitazone which does not contain the hindered phenol rese
mbling alpha -tocopherol), pioglitazone, or rosiglitazone for 12 h before h
arvesting. mRNA expression levels of TXR and AT1R were significantly decrea
sed by troglitazone in contrast to rosiglitazone, TXR gene and AT1R gene tr
anscription was significantly suppressed by troglitazone in a dose-dependen
t manner, while RS-1455 was less potent. Pioglitazone and rosiglitazone wea
kly suppressed the transcription of both genes in a manner almost similar t
o F18-1455. We have shown that troglitazone suppresses transcription of bot
h the TXR and AT1R genes more potently than other TZDs. The structure of tr
oglitazone and RS-1455 is identical except the hindered phenol, which is re
cently recognized to function as an antioxidant, Moreover, we have shown th
at the potency for activating PPAR-gamma is almost identical between trogli
tazone and RS-1455, We therefore speculate that the strong transcriptional
suppression of the TXR and AT1R genes by troglitazone may be mediated in pa
rt by its antioxidant effect.